A new phase III clinical trial of early stage breast cancer patients has shown that a molecule designed to home in on nearby lymph nodes is just as accurate as current techniques, but faster, more specific and easier to use.

3T MRI, a powerful tool for evaluating patients with a high risk of having breast cancer, can detect a significant number of breast cancer lesions not found on mammography and sonography, according to a study performed at the University of Toledo Medical Center, Toledo, OH.

A new study reveals that the metadherin gene (MTDH) plays a role in both cancer metastasis and resistance to chemotherapy. The research, published by Cell Press in the January 6th issue of the journal Cancer Cell, identifies MTDH as a promising therapeutic target for high risk breast cancers.

Breast-specific gamma imaging (BSGI) is effective in the detection of cancers not found on mammograms or by clinical exam, according to a study presented today at the annual meeting of the Radiological Society of North America (RSNA).

A study has found that positron emission mammography (PEM), a new technique for imaging the breast, is not affected by either breast density or a woman's hormonal status, two factors that limit the effectiveness of standard mammography and MRI at detecting cancer. Results will be presented today at the annual meeting of the Radiological Society of North America (RSNA).

Three-dimensional (3-D) power Doppler ultrasound helps radiologists distinguish between malignant and benign breast masses, according to a new study being published in the November issue of Radiology.

Jayant Vaidya, an Indian surgeon born in Goa, researching and teaching at the Dundee University in Scotland has pioneered a new method for the early detection of breast cancer.

A team of scientists created a new technology intended to detect breast cancer earlier and more precisely through intra-operative 3D imaging to win the 3rd Annual Intel+UC Berkeley Technology Entrepreneurship Challenge (IBTEC) last night. The Navaris Medical entry was judged by a team of venture capitalists from the San Francisco Bay Area.

A study in the Lancet could lead to a change of paradigm in the early diagnosis of breast cancer. It states that magnetic resonance imaging (MRI) is substantially more accurate than mammography in diagnosing very early stages of breast cancer . Up to now MRI was thought to be hardly suited for the detection of such 'ductal carcinoma in situ (DCIS) .

Magnetic resonance imaging (MRI) enables radiologists to accurately identify tumors missed by mammography and ultrasound, according to a multicenter study comparing the three screening methods in women at high-risk for breast cancer. The findings of the study appear in the August issue of the journal Radiology.

Mammogram readings by both radiologists and non-physician technologists improve breast cancer detection rates, according to a study in the July 24 Journal of the National Cancer Institute.

For women at high risk of breast cancer, use of magnetic resonance imaging (MRI) plus X-ray mammography for screening will detect more breast cancers than mammography alone, a new technology assessment has found. But the number of false positives —indicating a problem where none exists — will rise significantly also.